Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.44 USD | 0.00% | +23.08% | +111.76% |
04-18 | Imunon Receives FDA Approval to Start Phase 1 Trial of COVID-19 Booster Vaccine | MT |
04-18 | Imunon Shares Rise 8% After Clearance to Start Phase 1 Trial for Covid-19 Booster Vaccine | DJ |
Business Summary
Number of employees: 33
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Tardugno
CHM | Chairman | 73 | 02/01/07 |
Jeffrey Church
DFI | Director of Finance/CFO | 67 | 05/07/10 |
Sebastien Hazard
CTO | Chief Tech/Sci/R&D Officer | 53 | 12-10 |
Khursheed Anwer
CTO | Chief Tech/Sci/R&D Officer | 64 | 19/06/14 |
Kimberly Bragg
AUD | Comptroller/Controller/Auditor | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | 07/06/21 | |
Frederick Fritz
BRD | Director/Board Member | 73 | 07/07/11 |
James Dentzer
BRD | Director/Board Member | 57 | 02/10/22 |
Michael Tardugno
CHM | Chairman | 73 | 02/01/07 |
Donald Braun
BRD | Director/Board Member | 74 | 14/12/15 |
Stacy Lindborg
BRD | Director/Board Member | 53 | 03/06/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 9,399,811 | 9,291,441 ( 98.85 %) | 22 ( 0.000234 %) | 98.85 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+111.76% | 13.54M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- IMNN Stock
- Company Imunon, Inc.